EIT Health has announced a call for proposals targeting innovative digital and AI-powered medical technologies that are prepared for clinical validation and market introduction. The initiative aims to support selected projects by providing funding for pivotal clinical studies, the collection of real-world evidence to establish safety and efficacy, assistance with regulatory approval processes, and preparation for commercial market entry.
Program Scope and Funded Activities
• Project Duration: Funding will be awarded for a period of up to 24 months.
• Supported Activities: The grant supports activities that enable clinical validation such as pivotal clinical studies, regulatory submission including CE-mark application dossiers, product finalization, and the development of market readiness and commercial strategies.
Eligibility Criteria
• Consortium Requirement: Applicants must form a consortium of at least two organizations from different countries, representing a minimum of two sides of the Knowledge Triangle (industry, research, education).
• Leadership: The project must be led by a commercializing company.
• Solution Requirements: Eligible solutions are required to be digital or AI-enabled medical devices (MDR/IVDR).
• Maturity Level: Projects must be at an Innovation Maturity Level (IML) 6 at the start, with the goal of reaching IML 7 by the project's conclusion, as defined by EIT Health’s Healthcare Innovation Cycle Framework.
Funding Details
• Grant Amount: EIT Health will fund up to 50% of the total project budget, with a maximum grant of €850,000 per project.
• Agreement: The commercializing entity is required to sign a Financial Sustainability Contribution Agreement.
• SME Provision: In cases where the commercializing entity is a micro or small enterprise, it must receive between €400,000 and €500,000 of the total grant.
Expected Outcomes
• Patient Impact: Solutions must demonstrate the potential to impact 150,000 EU patients or citizens.
• Commercial Target: Projects should aim to be on the market and generating a minimum of €10,000 in revenues within three years following the funding period.
Key Dates and Deadlines
• Call Opens: 25 February 2026
• Call Closes: 6 May 2026
• Call Information Session: 18 March 2026, 12:00 CET
• Open Q&A Session 1: 08 April 2026, 12:00 CET
• Open Q&A Session 2: 22 April 2026, 12:00 CEST
Application and Networking Information
• Application Step 1: Organizations must register on the EU Funding & tender opportunities portal to receive a nine-digit Participant Identification Code (PIC number).
• Application Step 2: Proposals must be submitted through EIT Health’s official application platform.
• Matchmaking Event: EIT Health will host networking rounds on March 24, 25, and 26, 2026, for interested parties to connect with members and external partners.
• Matchmaking Registration: To participate in the networking rounds, registration is required by 20 March 2026.
This initiative offers a significant opportunity for innovators with advanced digital health solutions to accelerate their path to clinical validation and commercialization. For complete details, supporting documents, and application procedures, interested parties should refer to the official EIT Health call documentation.